Article
Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?
Human reproduction (Oxford, England) - 1 Oct 2020
Mackens Shari, Pareyn Stéphanie, Drakopoulos Panagiotis, Deckers Tine, Mostinckx Linde, Blockeel Christophe, Segers Ingrid, Verheyen Greta, Santos-Ribeiro Samuel, Tournaye Herman, De Vos Michel
Abstract excerpt
STUDY QUESTION: Does the phenotype of patients with polycystic ovary syndrome (PCOS) affect clinical outcomes of ART following in-vitro oocyte maturation? SUMMARY ANSWER: Cumulative live birth rates (CLBRs) after IVM were significantly different between distinct PCOS phenotypes, with the highest CLBR observed in patients with phenotype A/HOP (= hyperandrogenism + ovulatory disorder + polycystic ovaries), while...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
